Treatment Verification Overview

Principles

Definition

Treatment verification is a methodological approach used to confirm that a therapeutic intervention has been delivered accurately and as intended. It involves collecting and analyzing data, often during the treatment process, to assess parameters such as dosage, location, or patient positioning against the planned protocol. This process is significant for ensuring treatment efficacy and patient safety, as well as validating data in clinical research by providing evidence that the planned intervention was the one actually applied.

Ontological type

Verification Techniques

Clinical Objectives

Quality and Safety Standards

Key developments

Key Figures

CT-based 3D Planning era

Roger Dale [1], associated with The Open University [3], contributed to the CT-based 3D planning era by applying the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy in the paper The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy [6]. This work provided a quantitative framework for evaluating dose-fractionation strategies, supporting the reproducibility and optimization of plans in imaging-driven radiotherapy in this era [6]. D. K. Bewley [2], with ties to University of Chicago [4] and London Postgraduate Medical and Dental Education [5], contributed to early radiobiology and dosimetric verification through studies such as The fast neutron beam from the M.R.C. cyclotron [7]. Further work, including The Response of Pig Skin to Fractionated Treatments with Fast Neutrons and X rays [8] and The Effect of Fractionation on Four Day Survival of Mice after Whole-body Neutron Irradiation [9], helped establish quantitative tissue-response data and guided verification protocols during the era.

Image-Guided Motion Verification era

Marcel van Herk [1] is a leading figure in image-guided motion verification during the 1988–2009 era, with affiliations among Harvard University [3] and the Oncode Institute [4]. His key contributions include the development of dose-population histograms for deriving treatment margins in radiotherapy [6], the quantification of shape variation of the prostate and seminal vesicles during external beam radiotherapy [7], and strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer [8], which collectively advanced margin tailoring, motion assessment, and plan robustness crucial to this era. Joos V. Lebesque [2] also emerged as a key figure, associated with the Oncode Institute [4] and the University of Amsterdam [5] during this era. Lebesque's contributions center on the same foundational papers, notably the dose-population margins concept [6] and the prostate motion reduction strategies [8], which helped standardize image-guided verification and reduce uncertainties in dose delivery during that era.

Risk Based Adaptive Verification era

C J Martin [1] is associated with Wageningen University & Research [3] and the University of Glasgow [4] during this era. His key contribution centers on the ICRP Publication 135: Diagnostic Reference Levels in Medical Imaging [7], which codified standardized dose benchmarks and reporting practices that underpin risk-based verification and cross-center auditability. E. Vañó [2] is associated with Menlo School [5] and the Medical University of South Carolina [6] in this era. Her contribution, reflected in the same ICRP Publication 135 paper [7], helped establish diagnostic reference levels and harmonize imaging-dose guidelines critical for adaptive verification and quality assurance across centers.